Brii Biosciences (FRA:7SS) Net Margin %: -400.71% (As of Dec. 2025)


FRA:7SS Brii Biosciences Ltd FRA:7SS
33 GF Score
Price €0.10
! 1 Warning Sign
View Full Analysis

What is Brii Biosciences Net Margin %?

Brii Biosciences FRA:7SS -18.03% 33 Net Margin % is -400.71% as of Dec. 2025. GuruFocus rates FRA:7SS with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 947 Biotechnology companies, Brii Biosciences ranks worse than 80.15% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Brii Biosciences's Net Income for the six months ended in Dec. 2025 was €-9.04 Mil. Brii Biosciences's Revenue for the six months ended in Dec. 2025 was €2.26 Mil. Therefore, Brii Biosciences's net margin for the quarter that ended in Dec. 2025 was -400.71%.

The historical rank and industry rank for Brii Biosciences's Net Margin % or its related term are showing as below:

FRA:7SS' s Net Margin % Range Over the Past 10 Years
Min: -28329.48   Med: -1196.6   Max: -938.11
Current: -1188.2

FRA:7SS's Net Margin % is ranked worse than
80.15% of 947 companies
in the Biotechnology industry
Industry Median: -89.56 vs FRA:7SS: -1188.20

Brii Biosciences  (FRA:7SS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Brii Biosciences Net Margin % Related Terms

Brii Biosciences Net Margin % Historical Data

* Premium members only.

The historical data trend for Brii Biosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brii Biosciences Net Margin % Chart

Brii Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 0.00 -938.17 -28,421.52 0.00 -1,196.54

Brii Biosciences Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -400.71

FRA:7SS vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Brii Biosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brii Biosciences Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Brii Biosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Brii Biosciences's Net Margin % falls into.


FRA:7SS
33GF Score
Brii Biosciences Ltd FRA:7SS
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brii Biosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Brii Biosciences's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-26.994/2.256
=-1,196.54 %

Brii Biosciences's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-9.04/2.256
=-400.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -400.71% mean?
Brii Biosciences (FRA:7SS) has a Net Margin % of -400.71% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Brii Biosciences and its competitors. According to the industry distribution chart, Brii Biosciences ranks #759 out of 947 companies in the Biotechnology industry, placing it in the top 80.1%.
Is Brii Biosciences' Net Margin % too high?
Brii Biosciences' current Net Margin % is -400.71%. Based on the distribution chart, Brii Biosciences ranks #759 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Brii Biosciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Brii Biosciences' Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Brii Biosciences ranks #759 out of 947 companies for Net Margin %. This places Brii Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Brii Biosciences and its competitors. Brii Biosciences's current Net Margin % is -400.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brii Biosciences stock overvalued right now?
Brii Biosciences (FRA:7SS) has a current Net Margin % of -400.71%. The current Net Margin % is -400.71%. Brii Biosciences' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Brii Biosciences (FRA:7SS), the current Net Margin % is -400.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Brii Biosciences Business Description

Address No. 1 North Yongtaizhuang Road, 3rd Floor, Building 7, Zhongguancun Dongsheng, International Science Park, Haidian District, Beijing, CHN, 100192
Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed to developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as CNS diseases, which have public health burdens in China and around the world. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses.
33GF Score

Get the complete analysis for FRA:7SS

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price